| amine metabolic process | GO:0009308 | 45 | 0.310 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.303 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.238 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.164 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.128 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.113 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.108 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.103 | |
| transmembrane transport | GO:0055085 | 412 | 0.095 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.091 | |
| positive regulation of protein oligomerization | GO:0032461 | 4 | 0.088 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.083 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.082 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.081 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.080 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.077 | Yeast |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.075 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.074 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.073 | |
| anion transport | GO:0006820 | 177 | 0.072 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.072 | |
| regulation of cell motility | GO:2000145 | 236 | 0.071 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.070 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.070 | |
| membrane organization | GO:0061024 | 245 | 0.068 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.067 | |
| muscle tissue development | GO:0060537 | 308 | 0.066 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.065 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.064 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.063 | |
| male gamete generation | GO:0048232 | 285 | 0.063 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.062 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.062 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.062 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.061 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.058 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.058 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.058 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.058 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.058 | |
| immune effector process | GO:0002252 | 321 | 0.057 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.057 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.056 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.056 | |
| vesicle organization | GO:0016050 | 60 | 0.055 | |
| response to acid chemical | GO:0001101 | 111 | 0.054 | |
| gland development | GO:0048732 | 330 | 0.052 | |
| activation induced cell death of t cells | GO:0006924 | 10 | 0.052 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.051 | |
| modification by symbiont of host morphology or physiology | GO:0044003 | 4 | 0.050 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.049 | Human |
| angiogenesis | GO:0001525 | 201 | 0.048 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.047 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.047 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.046 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.046 | |
| muscle system process | GO:0003012 | 141 | 0.045 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.043 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.043 | |
| regulation of protein oligomerization | GO:0032459 | 4 | 0.043 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.043 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.043 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.043 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.042 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.042 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.042 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.041 | |
| glial cell apoptotic process | GO:0034349 | 3 | 0.041 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.041 | |
| circulatory system process | GO:0003013 | 197 | 0.040 | |
| regulation of cell migration | GO:0030334 | 219 | 0.040 | |
| extracellular structure organization | GO:0043062 | 148 | 0.040 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.039 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.039 | |
| steroid metabolic process | GO:0008202 | 119 | 0.039 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.039 | |
| neuron death | GO:0070997 | 154 | 0.039 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.038 | Yeast |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.038 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.038 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.037 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.037 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.037 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.037 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.036 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.036 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.036 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.036 | |
| multicellular organism growth | GO:0035264 | 161 | 0.036 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.036 | |
| regulation of interleukin 10 secretion | GO:2001179 | 4 | 0.036 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.036 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.036 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.036 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.035 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.035 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.035 | |
| spermatogenesis | GO:0007283 | 284 | 0.034 | |
| positive regulation of mitochondrial membrane permeability involved in apoptotic process | GO:1902110 | 11 | 0.034 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.034 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.034 | |
| ossification | GO:0001503 | 216 | 0.034 | |
| response to amino acid | GO:0043200 | 37 | 0.034 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.034 | |
| protein oligomerization | GO:0051259 | 67 | 0.033 | Yeast |
| compound eye development | GO:0048749 | 1 | 0.033 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.033 | Worm |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.033 | |
| protein ubiquitination | GO:0016567 | 171 | 0.033 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.033 | |
| positive regulation of intrinsic apoptotic signaling pathway | GO:2001244 | 25 | 0.033 | Worm |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.032 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.032 | Worm |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.032 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.032 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.032 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.031 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.031 | Human |
| positive regulation of protein homooligomerization | GO:0032464 | 3 | 0.031 | |
| urogenital system development | GO:0001655 | 261 | 0.031 | |
| blood circulation | GO:0008015 | 195 | 0.031 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.031 | |
| ear development | GO:0043583 | 200 | 0.030 | |
| response to inorganic substance | GO:0010035 | 96 | 0.030 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.030 | Human |
| tissue homeostasis | GO:0001894 | 115 | 0.030 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.030 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.029 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.029 | |
| spermatid differentiation | GO:0048515 | 115 | 0.029 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.029 | |
| gliogenesis | GO:0042063 | 141 | 0.029 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.029 | |
| cellular response to peptidoglycan | GO:0071224 | 4 | 0.029 | |
| fertilization | GO:0009566 | 127 | 0.028 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.028 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.028 | |
| chromatin organization | GO:0006325 | 206 | 0.028 | |
| response to radiation | GO:0009314 | 165 | 0.028 | |
| protein homooligomerization | GO:0051260 | 43 | 0.028 | Yeast |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.028 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.028 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.028 | |
| cellular homeostasis | GO:0019725 | 240 | 0.027 | |
| lipid transport | GO:0006869 | 98 | 0.027 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.027 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.027 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.027 | |
| placenta development | GO:0001890 | 140 | 0.027 | |
| endocrine system development | GO:0035270 | 98 | 0.027 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.027 | |
| spleen development | GO:0048536 | 39 | 0.027 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.027 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.027 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.026 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.026 | |
| regulation of cell activation | GO:0050865 | 289 | 0.026 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.026 | |
| metencephalon development | GO:0022037 | 89 | 0.026 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.026 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.026 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.026 | |
| rhythmic process | GO:0048511 | 174 | 0.026 | |
| cation transport | GO:0006812 | 399 | 0.026 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.026 | |
| tube formation | GO:0035148 | 140 | 0.026 | |
| protein localization to organelle | GO:0033365 | 185 | 0.026 | |
| dephosphorylation | GO:0016311 | 129 | 0.025 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.025 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.025 | |
| camera type eye development | GO:0043010 | 266 | 0.025 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.025 | Worm |
| mitochondrion organization | GO:0007005 | 134 | 0.025 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.025 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.025 | |
| histone modification | GO:0016570 | 159 | 0.025 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.025 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.025 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.025 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.025 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.025 | |
| renal system development | GO:0072001 | 225 | 0.025 | |
| connective tissue development | GO:0061448 | 179 | 0.024 | |
| hindbrain development | GO:0030902 | 128 | 0.024 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.024 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.024 | |
| cell adhesion | GO:0007155 | 329 | 0.024 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.024 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.024 | |
| regulation of developmental pigmentation | GO:0048070 | 14 | 0.024 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.024 | |
| regulation of protein homooligomerization | GO:0032462 | 3 | 0.024 | |
| protein processing | GO:0016485 | 163 | 0.024 | |
| regulation of ion transport | GO:0043269 | 215 | 0.024 | |
| mitochondrial membrane organization | GO:0007006 | 26 | 0.024 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.024 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.023 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.023 | |
| response to steroid hormone | GO:0048545 | 56 | 0.023 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.023 | |
| myotube differentiation | GO:0014902 | 105 | 0.023 | |
| b cell activation | GO:0042113 | 161 | 0.023 | |
| gtp catabolic process | GO:0006184 | 143 | 0.023 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.023 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.023 | |
| cellular response to lipid | GO:0071396 | 145 | 0.023 | |
| oxidation reduction process | GO:0055114 | 342 | 0.023 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.023 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.023 | |
| mitochondrial transport | GO:0006839 | 36 | 0.023 | |
| epithelial cell development | GO:0002064 | 159 | 0.022 | |
| cerebral cortex development | GO:0021987 | 86 | 0.022 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.022 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.022 | |
| muscle contraction | GO:0006936 | 101 | 0.022 | |
| circadian rhythm | GO:0007623 | 114 | 0.022 | |
| limb morphogenesis | GO:0035108 | 149 | 0.022 | |
| sensory perception | GO:0007600 | 245 | 0.022 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.022 | |
| kidney development | GO:0001822 | 213 | 0.022 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.022 | |
| regulation of system process | GO:0044057 | 200 | 0.022 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.022 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.022 | Worm |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.022 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.022 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.021 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.021 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.021 | |
| regionalization | GO:0003002 | 337 | 0.021 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.021 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.021 | |
| positive regulation of mitochondrion organization | GO:0010822 | 17 | 0.021 | |
| action potential | GO:0001508 | 78 | 0.021 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.021 | Human |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.021 | |
| response to peptide | GO:1901652 | 136 | 0.021 | |
| regulation of cell killing | GO:0031341 | 40 | 0.020 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.020 | |
| endomembrane system organization | GO:0010256 | 147 | 0.020 | |
| calcium ion transport | GO:0006816 | 159 | 0.020 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.020 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.020 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.020 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.020 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.020 | |
| respiratory system development | GO:0060541 | 190 | 0.020 | |
| positive regulation of release of cytochrome c from mitochondria | GO:0090200 | 5 | 0.020 | |
| cytokine production | GO:0001816 | 319 | 0.020 | |
| smooth muscle tissue development | GO:0048745 | 22 | 0.020 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.020 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.020 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.019 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.019 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.019 | |
| apoptotic process involved in mammary gland involution | GO:0060057 | 4 | 0.019 | |
| neural tube development | GO:0021915 | 160 | 0.019 | |
| t cell homeostasis | GO:0043029 | 35 | 0.019 | |
| pallium development | GO:0021543 | 120 | 0.019 | |
| negative regulation of interleukin 10 secretion | GO:2001180 | 2 | 0.019 | |
| respiratory tube development | GO:0030323 | 167 | 0.019 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.019 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.019 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.019 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.019 | |
| dna metabolic process | GO:0006259 | 303 | 0.019 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.019 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.019 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.019 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.018 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.018 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.018 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.018 | |
| intestinal epithelial structure maintenance | GO:0060729 | 4 | 0.018 | |
| t cell activation | GO:0042110 | 289 | 0.018 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.018 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.018 | |
| viral process | GO:0016032 | 41 | 0.018 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.018 | |
| peptide secretion | GO:0002790 | 114 | 0.018 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.018 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.018 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.018 | |
| glucose homeostasis | GO:0042593 | 128 | 0.018 | |
| inflammatory response | GO:0006954 | 244 | 0.018 | |
| skeletal system development | GO:0001501 | 356 | 0.018 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.018 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.018 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.018 | |
| modulation by virus of host morphology or physiology | GO:0019048 | 3 | 0.018 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.018 | |
| b cell apoptotic process | GO:0001783 | 19 | 0.018 | |
| stem cell differentiation | GO:0048863 | 268 | 0.018 | |
| viral life cycle | GO:0019058 | 36 | 0.018 | |
| detection of chemical stimulus involved in sensory perception of smell | GO:0050911 | 4 | 0.018 | |
| cell killing | GO:0001906 | 67 | 0.018 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.018 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.017 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.017 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.017 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.017 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.017 | |
| learning or memory | GO:0007611 | 148 | 0.017 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.017 | |
| ripoptosome assembly involved in necroptotic process | GO:1901026 | 6 | 0.017 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.017 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.017 | |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.017 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.017 | |
| organelle localization | GO:0051640 | 179 | 0.017 | |
| pigmentation | GO:0043473 | 71 | 0.017 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.017 | |
| organic anion transport | GO:0015711 | 137 | 0.017 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.017 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.017 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.017 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 27 | 0.017 | |
| renal system process | GO:0003014 | 48 | 0.017 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.017 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.016 | |
| regulation of protein localization | GO:0032880 | 231 | 0.016 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.016 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.016 | |
| response to oxygen levels | GO:0070482 | 62 | 0.016 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.016 | |
| forebrain development | GO:0030900 | 302 | 0.016 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.016 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.016 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.016 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.016 | |
| cell junction organization | GO:0034330 | 77 | 0.016 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.016 | |
| response to starvation | GO:0042594 | 65 | 0.016 | |
| regulation of ph | GO:0006885 | 26 | 0.016 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.016 | |
| axonogenesis | GO:0007409 | 274 | 0.016 | |
| interleukin 6 production | GO:0032635 | 58 | 0.016 | |
| mitochondrial outer membrane permeabilization involved in programmed cell death | GO:1902686 | 11 | 0.016 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.016 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.016 | |
| defense response to other organism | GO:0098542 | 197 | 0.016 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.016 | |
| cartilage development | GO:0051216 | 140 | 0.016 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.016 | |
| heart contraction | GO:0060047 | 93 | 0.016 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.016 | |
| regulation of cytokine secretion involved in immune response | GO:0002739 | 4 | 0.015 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.015 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.015 | |
| gtp metabolic process | GO:0046039 | 144 | 0.015 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.015 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.015 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.015 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.015 | |
| response to nutrient levels | GO:0031667 | 109 | 0.015 | |
| muscle cell development | GO:0055001 | 133 | 0.015 | |
| limb development | GO:0060173 | 166 | 0.015 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.015 | Human |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.015 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.015 | Worm |
| t cell mediated immunity | GO:0002456 | 50 | 0.015 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.015 | |
| appendage development | GO:0048736 | 166 | 0.015 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.015 | |
| notch signaling pathway | GO:0007219 | 71 | 0.015 | |
| positive regulation of apoptotic cell clearance | GO:2000427 | 3 | 0.015 | |
| protein catabolic process | GO:0030163 | 221 | 0.015 | |
| nephron development | GO:0072006 | 109 | 0.015 | |
| chemotaxis | GO:0006935 | 247 | 0.015 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.015 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.015 | Human |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.015 | |
| cognition | GO:0050890 | 149 | 0.015 | |
| hormone metabolic process | GO:0042445 | 86 | 0.014 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.014 | |
| positive regulation of mammary gland involution | GO:1903521 | 4 | 0.014 | |
| interaction with host | GO:0051701 | 22 | 0.014 | |
| innate immune response | GO:0045087 | 157 | 0.014 | |
| negative regulation of protein transport | GO:0051224 | 46 | 0.014 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.014 | |
| negative regulation of interleukin 5 secretion | GO:2000663 | 1 | 0.014 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.014 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.014 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 26 | 0.014 | |
| positive regulation of interferon alpha production | GO:0032727 | 4 | 0.014 | |
| alpha beta t cell activation involved in immune response | GO:0002287 | 31 | 0.014 | |
| actin filament organization | GO:0007015 | 113 | 0.014 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.014 | |
| cell growth | GO:0016049 | 130 | 0.014 | |
| organelle fission | GO:0048285 | 170 | 0.014 | |
| b cell differentiation | GO:0030183 | 78 | 0.014 | |
| embryonic placenta development | GO:0001892 | 98 | 0.014 | |
| neuronal action potential | GO:0019228 | 54 | 0.014 | |
| nucleotide sugar metabolic process | GO:0009225 | 4 | 0.014 | |
| cell cell junction organization | GO:0045216 | 72 | 0.014 | |
| epithelial tube formation | GO:0072175 | 130 | 0.014 | |
| atp metabolic process | GO:0046034 | 75 | 0.014 | |
| odontogenesis | GO:0042476 | 78 | 0.014 | |
| intracellular protein transport | GO:0006886 | 204 | 0.014 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.014 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.014 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.014 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.014 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.013 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.013 | |
| response to peptide hormone | GO:0043434 | 127 | 0.013 | |
| skin development | GO:0043588 | 220 | 0.013 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.013 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.013 | |
| striated muscle contraction | GO:0006941 | 45 | 0.013 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.013 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.013 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.013 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.013 | |
| regulation of ossification | GO:0030278 | 112 | 0.013 | |
| liposaccharide metabolic process | GO:1903509 | 27 | 0.013 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.013 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.013 | |
| regulation of interleukin 13 secretion | GO:2000665 | 2 | 0.013 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.013 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.013 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.013 | |
| regulation of mitochondrion organization | GO:0010821 | 27 | 0.013 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.013 | |
| retrograde transport endosome to golgi | GO:0042147 | 2 | 0.013 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.013 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.013 | |
| rna interference | GO:0016246 | 2 | 0.013 | |
| mapk cascade | GO:0000165 | 281 | 0.013 | |
| immunoglobulin production | GO:0002377 | 73 | 0.013 | |
| defecation | GO:0030421 | 1 | 0.013 | |
| kidney epithelium development | GO:0072073 | 121 | 0.013 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.013 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.013 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.013 | |
| neuron migration | GO:0001764 | 122 | 0.013 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.013 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 33 | 0.013 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.013 | |
| negative regulation of interleukin 5 production | GO:0032714 | 4 | 0.013 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.013 | Human |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.013 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.013 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.013 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.013 | |
| mesonephros development | GO:0001823 | 97 | 0.013 | |
| adaptive immune response | GO:0002250 | 155 | 0.013 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.013 | |
| protein maturation | GO:0051604 | 176 | 0.012 | |
| oxidative demethylation | GO:0070989 | 1 | 0.012 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.012 | |
| membrane fusion | GO:0061025 | 38 | 0.012 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.012 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.012 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.012 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.012 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.012 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.012 | |
| defense response to bacterium | GO:0042742 | 119 | 0.012 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.012 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.012 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.012 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.012 | |
| regulation of defense response | GO:0031347 | 233 | 0.012 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.012 | |
| protein alkylation | GO:0008213 | 81 | 0.012 | |
| transepithelial chloride transport | GO:0030321 | 4 | 0.012 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.012 | |
| somatic diversification of immunoglobulins | GO:0016445 | 43 | 0.012 | |
| necroptotic signaling pathway | GO:0097527 | 3 | 0.012 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.012 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.012 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.012 | |
| atp catabolic process | GO:0006200 | 55 | 0.012 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.012 | |
